Pages that link to "Q35826423"
Jump to navigation
Jump to search
The following pages link to Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice (Q35826423):
Displaying 27 items.
- In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201 (Q28349519) (← links)
- Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice (Q28379301) (← links)
- Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. (Q30353535) (← links)
- In vitro and in vivo assay systems for study of influenza virus inhibitors (Q34083704) (← links)
- Respiratory insufficiency correlated strongly with mortality of rodents infected with West Nile virus (Q34311960) (← links)
- Animal Models for Influenza Virus Pathogenesis and Transmission (Q34714853) (← links)
- In vivo anti-influenza virus activity of a zinc finger peptide (Q35134265) (← links)
- Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice (Q35647695) (← links)
- Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice (Q36607954) (← links)
- Influenza A virus inhibits alveolar fluid clearance in BALB/c mice (Q36960799) (← links)
- Extracellular hemin crisis triggers acute chest syndrome in sickle mice (Q37259191) (← links)
- A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice (Q37410786) (← links)
- Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection (Q37419706) (← links)
- The contribution of animal models to the understanding of the host range and virulence of influenza A viruses (Q37833239) (← links)
- Avian Influenza A Viruses: Evolution and Zoonotic Infection (Q38834987) (← links)
- Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice (Q40576505) (← links)
- Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201. (Q40772938) (← links)
- Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor (Q41042625) (← links)
- Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine (Q43177533) (← links)
- Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice (Q43640829) (← links)
- Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201. (Q43670720) (← links)
- Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice (Q43724540) (← links)
- Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors (Q43998626) (← links)
- Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812). (Q44601055) (← links)
- Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice (Q45401972) (← links)
- Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice (Q45743964) (← links)
- Effect of Methionine Enkephalin on Natural Killer Cell and Cytotoxic T Lymphocyte Activity in Mice Infected with Influenza a Virus (Q45787484) (← links)